Health Care/Hospital

ZEISS announces OCT technology enhancements to better support growing era of data-driven patient care

ZEISS Medical Ecosystem fortifies the CIRRUS 6000 with the U.S. market's largest OCT reference database and advanced cybersecurity features. DUBLIN, Calif., May 30, 2024 /PRNewswire/ -- ZEISS Medical Technology announced today that the CIRRUS® 6000 from ZEISS now enables a highly efficient and d...

2024-05-30 21:00 1817

Metabolon Announces 4-Week Turnaround Time for Commercial Projects, Enhancing Metabolomic Services for Multiomic Research

MORRISVILLE, N.C., May 30, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced a significant enhancement to its serv...

2024-05-30 20:57 1342

Illusion Aligners Makes Record-Breaking Achievement with its Biggest Aligner in India

MUMBAI, India, May 30, 2024 /PRNewswire/ -- In India's vibrant Dental fraternity, Illusion Aligners stands out as a trusted manufacturer of Clear Aligners. Renowned for its commitment to excellence and utilization of state-of-the-art technology, the brand has earned widespread recognition among ...

2024-05-30 18:58 2167

Preliminary Clinical Data on Relma-Cel Injection in Adults with Active Systemic Lupus Erythematosus in China at the Eular 2024 Congress

SHANGHAI, May 30, 2024 /PRNewswire/ -- JW (Cayman) Therapeutics Co. Ltd (the "Company" or "JW Therapeutics", together with its subsidiaries, the "Group"), an independent and innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, pres...

2024-05-30 18:10 2937

Kexing Biopharm Obtained Clinical Trial Approval for its Self-developed Class I Innovative Drug--Long-acting Growth Hormone

SHENZHEN, China, May 30, 2024 /PRNewswire/ -- On the 24th of May, Kexing Biopharm (688136.SH) announced that Shenzhen Kexing Pharmaceutical Co., Ltd., its wholly-owned subsidiary, recently received a Notice of Approval for Drug Clinical Trials from the National Medical Products Administration, ap...

2024-05-30 17:09 1422

Beame Expands Global Footprint

Dr. Philip Fan J.P. (范榮彰博士) Spearheads Provision of Premium Dental Services Aspiring to Benefit More People Worldwide HONG KONG, May 30, 2024 /PRNewswire/ -- Beame, a Hong Kong dental company founded by Dr.Philip Fan, J.P. (范榮彰博士), the former Chairman of the Board of Directors, Tung Wah Group of...

2024-05-30 12:27 1984

Transferable skills training is key as Singapore's healthcare sector grapples with manpower shortage

* Nearly nine in ten healthcare leaders (31% strongly agree, 59% somewhat agree) agree there is a shortage of healthcare professionals inSingapore, citing the provision of more competitive salary and benefit packages (57%), promoting preventive healthcare (41%), streamlining shift schedules (37...

2024-05-30 11:30 2126

Tigermed Advances Clinical Data Management with Veeva Vault EDC

Modern EDC streamlines key processes to accelerate study builds and make mid-study amendments with no downtime SHANGHAI, May 30, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV), the global leader in cloud solutions for the life sciences industry, today announced that Hangzhou Tigermed Consulting...

2024-05-30 09:38 2384

Full-Life Technologies Announces Clearance from FDA of IND Application for 225Ac-FL-020 for the Treatment of Metastatic Castration-Resistant Prostate Cancer

HEIDELBERG, Germany , May 29, 2024 /PRNewswire/ -- Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced it has received clearance of its Investigational New Drug (IND) Application from the U.S. Food and Drug Administration (FDA) for clinical tr...

2024-05-30 08:00 1250

Soterios Pharma Announces Positive Topline Results from Phase II Study of STS-01 in the Treatment of Mild / Moderate Alopecia Areata

* Once-daily topical treatment of mild / moderate alopecia areata (AA) with 1% STS-01 met the primary efficacy endpoint of >30% Severity of Alopecia Tool (SALT) score improvement compared to patients receiving placebo (p<0.0096) * Multiple secondary endpoints met with significant total hair re...

2024-05-30 07:05 3373

SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities

In collaboration with Microsoft and NVIDIA, SOPHiA GENETICS is developing a comprehensive whole genome analytical solution BOSTON and ROLLE, Switzerland, May 29, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven m...

2024-05-29 22:00 1617

HuidaGene and Synthego Announce Licensing Agreement on Next-Generation Gene Editing Enzyme, hfCas12Max

SHANGHAI and REDWOOD CITY, Calif. , May 29, 2024 /PRNewswire/ -- HuidaGene Therapeutics ("HuidaGene"), a global clinical-stage biotechnology company focused on advancing CRISPR-based genomic medicines, and Synthego Corporation ("Synthego"), a leading provider of innovative CRISPR solutions for de...

2024-05-29 19:30 2063

Veritas Genetics at the forefront of genomic screening with new studies presented at the European Society of Human Genetics Conference - ESHG 2024

* Veritas will present two pioneering studies at the European Society of Human Genetics Conference, inBerlin from June 1 to June 4. With a focus on elective genomic screening and newborn genomic screening, Veritas aims to set new standards in preventive medicine. * The Conference, now in its...

2024-05-29 17:55 1904

Onconic Therapeutics Announces Positive Phase 3 Results for JAQBO at Digestive Diseases Week 2024

SEOUL, South Korea and WASHINGTON, May 29, 2024 /PRNewswire/ -- Onconic Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for oncology and gastrointestinal disorders, announced today the results of its Phase 3 ZERO-1 study of JAQBO (zastaprazan...

2024-05-29 17:35 2239

Frost & Sullivan Reported The Fourth Revolutionary Wave of Biologics Manufacturing: CDMOs Empower Large-scale Production of Biologics

SHANGHAI, May 29, 2024 /PRNewswire/ -- Recently, Frost & Sullivan released the report "The Fourth Revolutionary Wave of Biologics Manufacturing: CDMOs Empower Large-scale Production of Biologics".  I.  CDMOs are advancing the biopharmaceutical industry with superior biomanufacturing capabilities...

2024-05-29 14:08 1773

Spectacular advances creating a revolution in the diagnosis and treatment of male infertility

MANILA, Philippines, May 29, 2024 /PRNewswire/ -- Spectacular advances in the diagnosis and treatment of male infertility are offering new hope to the one in six couples globally who seek assisted reproduction to achieve their dreams of parenthood. A major conference on human reproduction in t...

2024-05-29 12:42 1569

Key Innovations Unveiled at Hi & Fi Asia-China 2024

SHANGHAI, May 29, 2024 /PRNewswire/ -- As one of the most influential trade shows for health and functional ingredients inAsia, Hi & Fi Asia-China 2024 is set to deliver an extraordinary experience for attendees with its cutting-edge innovations and industry insights. The upcoming edition, taking...

2024-05-29 10:56 1509

US-Based Neurobiotic Leader Bened Life Launches Global Expansion with Neuralli™ MP

FREMONT, Calif., May 29, 2024 /PRNewswire/ -- Bened Life , the leader in psychobiotics, has begun worldwide expansion after finding success inthe United States with Neuralli™ MP - the first gut-brain medical probiotic for neurological conditions. Bened life is now spreadi...

2024-05-29 10:00 1845

US-Based Neurobiotic Leader Bened Life enters Japan market with Neuralli™ MP

FREMONT, Calif., May 29, 2024 /PRNewswire/ -- Bened Life , the leader in psychobiotics, has begun worldwide expansion after finding success inthe United States with Neuralli™ MP - the first gut-brain medical probiotic for neurological conditions. With investment from Teij...

2024-05-29 10:00 2455

SKT Launches AI-powered Veterinary Diagnostic Assistance Service X Caliber in Australia

* In collaboration with ATX Medical Solutions, SKT launches X Caliber in Australia, which has one of the highest rates of pet ownership in the world * SKT also inked a commercial contract with MEDIVET Pet Hospital & Clinic to offer X Caliber inIndonesia. SEOUL, South Korea, May 29, 2024 /PRNew...

2024-05-29 08:32 1482
1 ... 81828384858687 ... 847

Week's Top Stories